Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
EyePoint Pharmaceuticals, Inc. - Common Stock
(NQ:
EYPT
)
4.610
-0.380 (-7.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about EyePoint Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why's Going On With EyePoint Pharmaceuticals Stock Today?
September 11, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced interim masked safety data for its lead product candidate EYP-1901 from its ongoing Phase 2 PAVIA trial of EYP-1901 as a potential nine-month...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 05, 2023
Via
Benzinga
Where EyePoint Pharmaceuticals Stands With Analysts
July 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 13, 2023
Via
Benzinga
Why Are EyePoint Pharmaceuticals Shares Trading Higher Today
July 10, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) shares are trading higher after the company appointed Jay Duker as chief executive officer, transitioning from his most recent role as chief operating
Via
Benzinga
What 6 Analyst Ratings Have To Say About EyePoint Pharmaceuticals
June 28, 2023
Via
Benzinga
5 Analysts Have This to Say About EyePoint Pharmaceuticals
June 06, 2023
Via
Benzinga
EyePoint Pharmaceuticals: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Earnings Preview: EyePoint Pharmaceuticals
March 01, 2023
Via
Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
June 14, 2023
JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
June 14, 2023
Via
Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
May 18, 2023
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).
Via
InvestorPlace
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
May 18, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM).
Via
Benzinga
Why EyePoint Pharmaceuticals Shares Are Shooting Higher Today
May 03, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) reported Q1 revenues of $7.68 million, down from $9.3 million a year ago but slightly
Via
Benzinga
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments
May 02, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Intraday Session
April 24, 2023
Via
Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday
April 24, 2023
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
April 21, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...
Via
Benzinga
EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equities by Percentage Gain on 4/21
April 21, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Intraday Session
April 21, 2023
Via
Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
April 21, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...
Via
Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
April 21, 2023
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
Eyepoint Pharmaceuticals Inc. (NASDAQ: EYPT) Leading the Way in Monday Trading Based on Percentage Gain
March 27, 2023
Via
Investor Brand Network
Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank's Fallout
March 16, 2023
Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies.
Via
Benzinga
EyePoint Pharma Posts Deeper Losses For Q4, Expects Cash Runway Into 2024
March 02, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported Q4 revenues of $10.5 million, down 8.8% Y/Y, almost in line with the consensus of $10.40 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 12, 2023
Via
Benzinga
EYEPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint Pharmaceuticals, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm
December 28, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.